Cancer Epidemiology
Volume 34, Issue 1 , Pages 34-39 , February 2010

Risk factors for breast cancer in women biopsied for benign breast disease: A nested case-control study

  • Geoffrey C. Kabat

      Affiliations

    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 718 430 3038; fax: +1 718 430 8653.
    • ,
  • Joan G. Jones

      Affiliations

    • New York - Presbyterian Hospital, 525 East 68th St., Starr 1015, New York, NY 10032, United States
    • ,
  • Neal Olson

      Affiliations

    • Center for Health Research, Kaiser Permanente Northwest, 3800N. Interstate Avenue, Portland, OR 97227-1098, United States
    • ,
  • Abdissa Negassa

      Affiliations

    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States
    • ,
  • Catherine Duggan

      Affiliations

    • Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue, N. Seattle, WA 98109, United States
    • ,
  • Mindy Ginsberg

      Affiliations

    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States
    • ,
  • Rita A. Kandel

      Affiliations

    • Department of Pathology and Laboratory Medicine, Mt. Sinai Hospital, 600 University Avenue, Suite 6-500, Toronto, Ontario, Canada M5G 1X5
    • ,
  • Andrew G. Glass

      Affiliations

    • Center for Health Research, Kaiser Permanente Northwest, 3800N. Interstate Avenue, Portland, OR 97227-1098, United States
    • ,
  • Thomas E. Rohan

      Affiliations

    • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, United States

,Accepted 9 December 2009.

References 

  1. Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol. 2003;27:836–841
  2. Rohan TE, Henson DE, Franco EL, Albores-Saavedra J. Cancer precursors. In:  Schottenfeld D,  Fraumeni JF editor. Cancer epidemiology and prevention. 3rd ed.. New York: Oxford University Press; 2006;
  3. Lakhani SR. The transition from hyperplasia to invasive carcinoma of the breast. J Pathol. 1999;187:272–278
  4. Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia. 1998;3:49–61
  5. Colditz GA, Baer HJ, Tamimi RM. Breast cancer. In:  Schottenfeld D,  Fraumeni JF editor. Cancer epidemiology and prevention. 3rd ed.. New York: Oxford University Press; 2006;p. 995–1012
  6. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267:941–944
  7. Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71:1258–1265
  8. Wang J, Constantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N. Lower-category benign breast disease and the risk of invasive cancer. J Natl Cancer Inst. 2004;96:616–620
  9. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. New Engl J Med. 2005;353:229–237
  10. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia. Cancer. 2007;109:180–187
  11. Degnim AC, Visscher DW, Berman HK, Frost MH, Sellars TA, Vierkant RA, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007;25:2671–2677
  12. Worsham MJ, Raju U, Lu M, Kapke A, Bottrell A, Cheng J, et al. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat. 2009;118:1–7
  13. Thomas DB, Persing JP, Hutchinson WB. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. J Natl Cancer Inst. 1982;69:1017–1025
  14. Dupont WD, Page DL, Rogers LW, Parl FF. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer. 1989;63:948–957
  15. Dupont WD, Page DL, Parl FF, Plummer WD, Schuyler PA, Kasami M, et al. Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer. 1999;85:1277–1283
  16. Byrne C, Connolly JL, Colditz GA, Schnitt SJ. Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma. Cancer. 2000;89:2046–2052
  17. Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M, Kandel RA, Glass AG, Rohan TE. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancerbreast disease and risk of subsequent breast cancer. Cancer Causes Control (in press).
  18. Page DL, Anderson TJ. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone; 1987;
  19. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk of subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998;122:1053–1055

☆ Grant support: This work was supported by NIH: RO1-CA95661-01 “p53 in BBD and breast cancer risk: a multi-center cohort”.

PII: S1877-7821(09)00184-2

doi: 10.1016/j.canep.2009.12.005

Cancer Epidemiology
Volume 34, Issue 1 , Pages 34-39 , February 2010

Article Tools